SBS-1000 (safflower produced insulin biosimilar)
/ SemBioSys Genetics
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 21, 2010
SemBioSys appoints president of US and international operations and announces the appointments of three vice presidents
(PRNewswire)
-
Rick Pierce has joined the company as President of US and International Operations;
March 31, 2011
SemBioSys announces 2010 financial and operational results
(Newswire.ca)
-
Advanced partnering discussions for its biosimilar insulin and Apo AIMilano programs with a very focused emphasis on China and companies with synergies for its technology platform and products; Net loss FY ’10 vs. FY ’09 is $8,260,239
Diabetes
1 to 2
Of
2
Go to page
1